Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer

Tetsushi Tsuruga1, Shunsuke Nakagawa, Michiko Watanabe

  • 1Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.

Oncology Research
|December 14, 2007
PubMed

Insights

Loss of Hugl-1 expression in endometrial cancer correlates with increased lymph node metastasis and poorer prognosis. This finding suggests Hugl-1

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neoplastic tumor suppressor genes like scribble, discs large, and lethal giant larvae (lgl) regulate cell polarity and proliferation.
  • Reduced expression of the human homologue of lgl (Hugl-1) is implicated in colon cancer and malignant melanoma progression.

Purpose of the Study:

  • To investigate the association between Hugl-1 expression and clinical characteristics in endometrial cancer.
  • To determine if Hugl-1 expression levels correlate with patient prognosis in endometrial cancer.

Main Methods:

  • Examined Hugl-1 mRNA expression in 86 primary endometrial cancer tissues using semiquantitative reverse transcription polymerase chain reaction (RT-PCR).
  • Categorized samples into Hugl-1 positive and negative groups.
  • Analyzed clinical data and survival rates using Fisher's exact probability test, Kaplan-Meier method, and Log-rank test.

Main Results:

  • Loss of Hugl-1 expression was significantly correlated with a higher incidence of lymph node metastasis.
  • No significant correlation was found between Hugl-1 expression and patient age, distant metastasis, clinical stage, lymph or venous vessel invasion, or histopathological grade.
  • The Hugl-1-positive group exhibited a poorer prognosis compared to the Hugl-1-negative group.

Conclusions:

  • Loss of Hugl-1 expression in endometrial cancer may promote lymph node metastasis.
  • Reduced Hugl-1 expression is a potential indicator of poor prognosis in endometrial cancer patients.